A detailed history of Graham Capital Management, L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 13,038 shares of BMRN stock, worth $868,721. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,038
Previous 7,329 77.9%
Holding current value
$868,721
Previous $603,000 51.91%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $394,035 - $535,732
5,709 Added 77.9%
13,038 $916,000
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $1.08 Million - $1.33 Million
-14,453 Reduced 66.35%
7,329 $603,000
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $1.83 Million - $2.16 Million
21,782 New
21,782 $1.9 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $3.49 Million - $4.03 Million
40,223 New
40,223 $3.49 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $2.18 Million - $2.57 Million
26,503 Added 588.96%
31,003 $2.63 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $927,595 - $1.13 Million
-12,977 Reduced 74.25%
4,500 $372,000
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $1.04 Million - $1.3 Million
14,056 Added 410.87%
17,477 $1.35 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $245,354 - $312,918
3,421 New
3,421 $302,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.